Coronary artery bypass grafting (CABG) is a surgical procedure used to treat individuals with coronary artery disease. During the procedure, a healthy artery or vein from the leg, arm or chest is grafted to bypass narrowed or blocked arteries in the heart. CABG is considered an effective treatment for restoring blood flow to the heart muscle which lowers the risk of a heart attack. Growing prevalence of cardiovascular diseases such as heart attacks, strokes and peripheral artery disease is considered as a major factor driving the demand for CABG procedures globally.
The global Coronary Artery Bypass Grafting Market is estimated to be valued at USD 14.02 Bn in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period 2024 to 2031.
Key players operating in the coronary artery bypass grafting market are Medtronic, Terumo Medical Corporation, Getinge, LivaNova PLC, Sorin Group, Edwards Lifesciences Corporation.
Key Takeaways
Key players in the coronary artery bypass grafting market:
Medtronic, Terumo Medical Corporation, Getinge, LivaNova PLC, Sorin Group and Edwards Lifesciences Corporation hold majority share in the global CABG market. Medtronic offers a wide portfolio of CABG products including grafts and anastomosis devices. Terumo Medical Corporation is a leading manufacturer of vascular grafts for CABG procedures.
Key opportunities:
Rise in surgical volume in emerging economies of Asia Pacific and Latin America driven by growing disease incidence and healthcare infrastructure advances presents lucrative Coronary Artery Bypass Grafting Market Demand. Furthermore, adjunctive therapies to CABG such as endoscopic vascular harvesting improves outcomes and expand the market potential.
Global expansion:
Major players are engaged in geographic expansion through acquisitions and partnerships to increase their global footprint. For instance, Medtronic acquired cardiac surgery company Aortic to expand in aortic surgery. Sorin Group merged with LivaNova to become a global leader in heart-lung machines used in CABG.
Market drivers and restrain
The major market driver is the growing prevalence of cardiovascular diseases mainly due to risk factors like obesity, physical inactivity and smoking. Advancements in minimally invasive surgical techniques, robotic-assisted surgery and drug eluting stents have prompted increased adoption of CABG over angioplasty and stent placement. However, high cost of CABG procedures and preference for less invasive therapies limit the market growth to some extent.
Segment Analysis
The coronary artery bypass grafting market can be segmented based on product, services, and site. By product type, the saphenous vein grafts segment holds a major share as they are most commonly used for bypass surgery. Saphenous vein grafts from the patient's leg are used to bypass the coronary artery blockages. It dominates the market as it is a well-established procedure and has long term benefits and survival rates. By services, the open-heart CABG surgery dominates as it provides direct visualization of the heart which ensures effective grafting and treatment of complex blockages. By site, the off-pump CABG surgery segment is growing rapidly as it has advantages such as reduced postoperative bleeding, blood transfusion requirements, and hospital stay with an earlier return to normal activity compared to conventional OPCAB.
Regional Analysis
North America dominates the global market and is expected to continue its dominance during the forecast period due to the increasing prevalence of coronary artery diseases, rising obesity rates, growing geriatric population. The region has well-developed healthcare infrastructure and high awareness regarding cardiac care. Europe holds the second largest share due to the rising adoption of advanced devices and techniques for CABG in countries such as Germany, UK, and France. The Asia Pacific region is anticipated to grow at the fastest rate owing to improving healthcare infrastructure, increasing healthcare spending, and growing medical tourism in countries such as India, China, and Malaysia. Rapid urbanization and changing lifestyle leading to increased heart diseases are also contributing to the regional market growth.
Get this Report in Japanese Language- 冠動脈バイパス移植市場
Get this Report in Korean Language- 관상동맥 우회술 시장
About Author-
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Known for her strong SEO background, she skillfully blends SEO strategies with insightful content. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
